Trial Profile
Clinical Trials Insight: 700021549
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2009
Price :
$35
*
At a glance
- Drugs Vadimezan (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Sponsors Antisoma
- 21 May 2009 Results have been published in the journal Lung Cancer, according to an Antisoma media release.
- 01 Jun 2008 Results presented at ASCO 2008.
- 13 Sep 2007 Status changed from in progress to completed.